AzTrials
AzTrials

Dental ImplantNCT07889882

Clinical and Radiographic Comparison of Two Implant-Abutment Connections

A study testing N1 Dental implant placement + N1 abutment and Nobel active Implant placement + on1 abutment in people with Dental Implant and Edentulous Alveolar Ridge, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this clinical study is to evaluate two different implant-abutment connection design on preserves gingiva and bone health in the long term. As part of this study, two different implant systems will be applied to the posterior edentulous areas on both sides of the mouth. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dental Implant, Edentulous Alveolar Ridge
What is being tested?
N1 Dental implant placement + N1 abutment and Nobel active Implant placement + on1 abutment
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Oct 2026to 5 Sep 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age>18 years old,
  • patients have two posterior single edentulous fully-healed sites at different quadrants,
  • sufficient alveolar width without the need for additional alveolar augmentation or immediate bone grafting, as assessed by Cone Beam Computed Tomography (CBCT),
  • cooperated,
  • systemically healthy patients.

Who cannot join

  • pregnancy and breastfeeding,
  • individuals with intellectual disabilities,
  • immediate implant placement,
  • Untreated periodontitis (Full mouth plaque score > 20%, full mouth bleeding score > 25%, residual pocket depth > 5 mm),
  • heavy smoking (>10 cigarettes/day),
  • usage drugs that suppress the immune system or impair recovery or that disrupt bone metabolism such as chemotherapy, radiotherapy etc.,
Show all 10Show fewer
  • severe bruxism or clenching,
  • bone augmentation during implant surgery,
  • prosthetic contraindications,
  • penicillin allergy history.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Berceste Guler Ayyildiz, Assoc. Prof. Dr. contact

+90 02742300056

berceste.guler@ksbu.edu.tr

Busra Terzioglu, Assist. Prof. Dr. contact

+905345228670

busra.ozaltun@ksbu.edu.tr

Turkey (Türkiye)1 site
  • Kütahya Health Sciences University Gülsüm Güral Oral and Dental Health Application and Research Center

    Kütahya, 43020

    Berceste Guler Ayyildiz, Assoc. Prof. Dr., +905059359207, berceste.guler@ksbu.edu.tr

    Busra Terzioglu, Assist. Prof. Dr., +905345228670, busra.ozaltun@ksbu.edu.tr

Other trials in Turkey (Türkiye)

About this study

Official title: Clinical and Radiographic Comparison of Dental Implants With Trioval and Conical Implant-Abutment Connections

The aim of this clinical study is to evaluate two different implant-abutment connection design on preserves gingiva and bone health in the long term.

As part of this study, two different implant systems will be applied to the posterior edentulous areas on both sides of the mouth. Implants featuring a new macro-design and a special surface technology (TiUltra surface and N1 system), aimed at accelerating tissue healing, will be placed in one area; meanwhile, implants with a conical design and the same special surface technology, which are widely used in clinical practice (Nobel Active), will be placed in the other area.

Read more

Procedure for Participants First, an intraoral examination will be performed, and CBCT will be taken to assess suitability for the procedure.

Surgical Procedure: Implant placement. Prosthetic Phase: Once healing is complete, impressions will be taken, and porcelain teeth will be placed on the implants.

Follow-up Appointments: Follow-ups will be conducted at 1, 3, 6, and 12 months following the placement of the teeth. During these check-ups, gingiva health will be assessed, and X-rays will be taken to observe changes in bone levels.

Read the detailed description

This study aims to compare the effect of the N1 implant system, featuring a new macro design with a TiUltra surface and a trioval implant-abutment connection placed in the posterior region as a splitmouth in single-unit implants, with that of Xeal abutments on Nobel Active conical connection implants, also featuring a TiUltra surface, on peri-implant marginal bone loss.

The stability of both soft and hard tissues is crucial for maintaining long-term peri-implant tissue health. In this context, various surface modifications have been studied to enhance osseointegration. Developed in recent years to optimize tissue integration at all levels of the implant, TiUltra™ surface features an ultra-hydrophilic, multi-zone, and anodized surface architecture. The TiUltra™ surface topography gradually changes from the implant neck to the apex, providing a biocompatible and stable surface at the soft tissue level while supporting osseointegration with a moderately rough and porous structure at the apex. A healthy soft tissue barrier, defined as peri-implant soft tissue integration (mucointegration), plays a critical role in protecting peri-implant bone by preventing bacterial colonization and related inflammatory processes. Therefore, in recent years, focus has been placed on implant and abutment connection design, surface topography, and surface chemistry. Various strategies have been used to maintain peri-implant tissue stability, including platform switching, transmucosal abutments, two-piece abutments, and modifications to the implant collar and implant-abutment interface, such as one-abutment one-time concepts. A new biology-driven implant concept has also been developed to improve osseointegration and mucointegration: the Nobel Biocare N1™ system. The system: It is based on a biological concept that combines the OsseoShaper™ cutting tool, which protects vital bone with low speed, irrigation-free operation, the OsseoDirector™, which guides implant positioning, the Xeal surfaced On1 abutment, and the TiUltra-surfaced N1 implant.

All implants will be placed using standard surgical protocols by the same brand. The implants will be placed in both groups during the same session. Local anesthesia will be achieved in surgical areas using the bilateral vestibular infiltration technique. A crestal incision will be made using a size 15 scalpel, and the mucoperiosteal flap will be elevated. In the test group, following the manufacturer's protocol, the implant site. The Nobel Biocare N1™ Implant will insert subcrestally at 25 rpm with an insertion torque of 35 Ncm. In the control group, osteotomy preparations are performed at 600-800 rpm, after which the Nobel TiUltra Active implants are placed subcrestally with an insertion torque of 35 Ncm. Following primary stabilization, the heights of the definitive two-piece abutments will be determined at the time of implant placement surgery based on the supracrestal tissue height, with heights of 1.75 mm and 2.5 mm recorded in both groups. The On1/N1 healing abutment will then be fitted on N1/On1 Base, and the surgical field will be sutured. The dental implant sites will primarily be closed with 4-0 resorbable Vicryl sutures. On1/N1 Temporary abutments will be placed, and temporary crowns will be delivered at the same day with operation day. After implant placement, a temporary abutment designed explicitly for temporary prosthesis application and a temporary prosthesis with approximately 1 mm infraocclusion will be fabricated. Following the dental implant treatment after 3 months, On1/N1 universal abutments will be torqued and screwed-retained porcelain fused to metal prosthetic final restorations will be delivered.

Clinical and Intraoperative Measurements Before the operation, keratinized mucosal width (KMW) and mucosal thickness (MT) will be measured at baseline (Tb).

Peri-implant clinical measurements: modified plaque index (mPI), modified gingival index (mGI), periodontal pocket depth (PD), bleeding on probing % (BOP%), KMW, and MT will be recorded at permanent prosthetic functional loading (T0), 1 month (T1), 3 month (T2), 6 months (T3), and 12 months (T4) following prosthetic functional loading. Mesial and distal adjacent to single-unit dental implants will be recorded as tooth or edentulous. Intraoperatively, implant placement depth at mesial, distal, buccal, and lingual aspects will be recorded. And also, supracrestal tissue height will be measured.

Digital aesthetic assessment in the study will be performed by superimposing intraoral scans and radiological images on a digital platform.

Marginal bone level will be measured in standardized periapical digital radiographs. Periapical radiographs will be obtained with the parallel long-cone technique with O-ring film-holder after immediately implant placement, at prosthesis functional loading (following 4 months of implant placement) (T0), 1 month (T1), 3 month (T2), 6 months (T3), and 12 months (T4) after prosthesis loading.

Being tested
N1 Dental implant placement + N1 abutment, Nobel active Implant placement + on1 abutment
Keywords
posterior mandible, posterior maxilla, edentulous, dental implant, connection design
Medical subject headings
Mouth, Edentulous

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • N1 Dental implant placement + N1 abutmentProcedure or surgery

    All implants will be placed by the same 15-year-experienced periodontist (B.G.A) under local anesthesia with a crestal incision and flap elevation. For the N1 group, the implant site is prepared using the OsseoDirector at 600-800 rpm with irrigation to determine direction and depth. The osteotomy is then prepared with OsseoShaper™ 1 at 50 rpm without irrigation. A Nobel Biocare N1™ Implant will be inserted subcrestally at 25 rpm with a 35 Ncm insertion torque. Based on supracrestal tissue height (1.75-2.5 mm), an N1 Base Xeal abutment will be torqued to 25-30 N-cm. An N1 healing abutment will be fitted, and the site closed with 4-0 Vicryl sutures. An N1 temporary abutment and a temporary crown with ~1 mm infraocclusion will be delivered on the same day. After 3 months, N1 universal abutments will be torqued, and screw-retained porcelain-fused-to-metal final restorations will be delivered.

  • Nobel active Implant placement + on1 abutmentProcedure or surgery

    All implants will be placed by the same 15-year-experienced periodontist (B.G.A) under local anesthesia with a crestal incision and flap elevation. For the on1 group, osteotomy preparations are performed at 600-800 rpm, after which the Nobel TiUltra Active implants are placed subcrestally with an insertion torque of 35 Ncm. Based on supracrestal tissue height (1.75-2.5 mm), an On1 Base Xeal abutment will be torqued to 25-30 N-cm. An On1 healing abutment will be fitted, and the site closed with 4-0 Vicryl sutures. An On1 temporary abutment and a temporary crown with ~1 mm infraocclusion will be delivered on the same day. After 3 months, On1 universal abutments will be torqued, and screw-retained porcelain-fused-to-metal final restorations will be delivered.

Study groups in NCT07889882
Study groupRoleWhat they receive
N1ExperimentalFollowing dental implant placement (Nobel Biocare, N1 Implant system, Switzerland), an N1 Base and healing abutment will be immediately placed at intraoperatively and a temporary crown will be delivered at the same day. After three months, N1 universal abutments with porcelain-fused metal, screw-retained prosthetic restorations will be delivered.
Receives: Procedure: N1 Dental implant placement + N1 abutment
On1ExperimentalFollowing dental implant placement (Nobel Biocare, TiUltra Active, Switzerland), an On1 Base and healing abutments will be immediately placed at intraoperatively, and a temporary crown will be delivered at the same day. After three months, On1 universal abutments with porcelain-fused metal, screw-retained prosthetic restorations will be delivered.
Receives: Procedure: Nobel active Implant placement + on1 abutment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Marginal bone level changes (mm)

    The primary outcome measure will be ΔMBL (Marginal bone level changes) at T0 (prosthetic loading) -T4 (12 months follow-up) on periapical radiographs

    Measured: 12 months follow-up

Secondary outcomes (2)
  1. Correlation between marginal bone level changes and other parameters

    Secondary outcome measures will be the correlation between Marginal bone level changes (ΔMBL ) at T0 (prosthetic loading) -T4 (12 months follow-up) and implant diameter, implant length, emergence angle, emergence profile, abutment connection/disconnection, abutment height, adjacent area, clinical measurements, and the digital evaluation of the peri-implant soft tissue.

    Measured: 12 months follow-up

  2. Primary and secondary outcomes (ISQ)

    Resonance frequency analysis will be measured at postoperatively and prosthetic functional loading session as ISQ values.

    Measured: At operation and follow-up 3 months (at prosthetic loading)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2026
  2. Study start26 Oct 2026 (estimated)
  3. Primary completion5 Jun 2029 (estimated)
  4. Study completion5 Sep 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A prospective, split-mouth, randomized, parallel-designed, blinded, clinical trial.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07889882
Sponsor's protocol ID
BGA2601
Other IDs
2026-1873
Status last verified
Oct 2026
First submitted
12 Oct 2026
Last updated
22 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Wennerberg A, Albrektsson T, Chrcanovic B. Long-term clinical outcome of implants with different surface modifications. Eur J Oral Implantol. 2018;11 Suppl 1:S123-S136.

    PubMed 30109304
  • Chen CH, Coyac BR, Arioka M, Leahy B, Tulu US, Aghvami M, Holst S, Hoffmann W, Quarry A, Bahat O, Salmon B, Brunski JB, Helms JA. A Novel Osteotomy Preparation Technique to Preserve Implant Site Viability and Enhance Osteogenesis. J Clin Med. 2019 Feb 1;8(2):170. doi: 10.3390/jcm8020170.

    PubMed 30717291
  • Fabbri G, Staas T, Urban I. A Retrospective Observational Study Assessing the Clinical Outcomes of a Novel Implant System with Low-Speed Site Preparation Protocol and Tri-Oval Implant Geometry. J Clin Med. 2022 Aug 18;11(16):4859. doi: 10.3390/jcm11164859.

    PubMed 36013098
  • Nosswitz M, Teale M, Mathes S, et al. Evaluation of anodized surfaces designed for improved soft tissue integration. Foundation for Oral Rehabilitation (FOR) 2019;1-7.

  • Ayyildiz BG, Terzioglu B, Bayindir BC. The Effect of Two-Piece Abutment Concept and Abutment Reconnection/Disconnection on Marginal Bone Level Changes: A Split-Mouth Randomized, Parallel-Designed, 36-Month Follow-Up, Preliminary Clinical Study. Int J Oral Maxillofac Implants. 2025 Sep 4;0(0):1-28. doi: 10.11607/jomi.11454. Online ahead of print.

    PubMed 40907027
  • Laleman I, Lambert F. Implant connection and abutment selection as a predisposing and/or precipitating factor for peri-implant diseases: A review. Clin Implant Dent Relat Res. 2023 Aug;25(4):723-733. doi: 10.1111/cid.13185. Epub 2023 Feb 24.

    PubMed 36825512
  • Yeung SC. Biological basis for soft tissue management in implant dentistry. Aust Dent J. 2008 Jun;53 Suppl 1:S39-42. doi: 10.1111/j.1834-7819.2008.00040.x.

    PubMed 18498584

Questions about this trial

What is this clinical trial studying?

A study testing N1 Dental implant placement + N1 abutment and Nobel active Implant placement + on1 abutment in people with Dental Implant and Edentulous Alveolar Ridge, run by Kutahya Health Sciences University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Berceste Guler Ayyildiz, Assoc. Prof. Dr. (+90 02742300056, berceste.guler@ksbu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Marginal bone level changes (mm) (time frame: 12 months follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07889882, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in